| |
| Issue |
Title |
| |
| No 2 (2024) |
Revolutionizing healthcare: the role of CRISPR-Cas systems in precision medicine |
Abstract
PDF (Rus)
|
|
Eskandar Kirolos |
| |
| No 2 (2024) |
Genetic factors contributing to the development of metabolic syndrome |
Abstract
PDF (Rus)
|
|
C. E. Kalashnikova, E. V. Shrayner, V. I. Bystrova, G. I. Lifshits |
| |
| No 2 (2024) |
Cough associated with angiotensin-converting enzyme inhibitors: the role of pharmacogenetics |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 2 (2024) |
Pharmacogenetic features of angiotensin-converting enzyme inhibitors |
Abstract
PDF (Rus)
|
|
B. I. Kantemirova, O. V. Komarova, A. N. Romanova |
| |
| No 1 (2024) |
Strategy and technologies of distribution and implementation of pharmacogenomics in clinical practice: foreign experience |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 1 (2023) |
Molecular genetic features of hereditary forms of breast cancer (systematic review) |
Abstract
PDF (Rus)
|
|
A. V. Serebryakova, K. A. Aliyev, L. E. Sorokina, O. Yu. Gritskevich, E. Yu. Zyablitskaya |
| |
| No 1 (2021) |
Importance of using a pharmacogenetic approach to predict individual pharmacokinetics and safety profile of apixaban |
Abstract
PDF (Rus)
|
|
L. V. Fedina, I. N. Sychev, D. A. Sychev |
| |
| No 1 (2021) |
ADRB2 gene polymorphism and preterm labor |
Abstract
PDF (Rus)
|
|
R. E. Kazakov, R. A. Chilova, K. O. Akopov, E. A. Sokova |
| |
| No 1 (2020) |
Problems of integrating medical science, image and practical health care: focus on personalized medicine |
Abstract
PDF (Rus)
|
|
D. A. Sychev, L. K. Moshetova |
| |
| No 1 (2016) |
Pharmacogenetics of arterial hypertension: pharmacogenetic of torasemide |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 1 (2016) |
The perspectives of development for pharmacogenetic and pharmacokinetic approaches to personalized use of target therapy in chronic myeloid leukemia |
Abstract
PDF (Rus)
|
|
M. I. Savelyeva |
| |
| No 1 (2016) |
Pharmacogenetics for glaucoma: present and future |
Abstract
PDF (Rus)
|
|
D. A. Sychev, A. V. Rozhkov, I. V. Alekseev |
| |
| No 2 (2016) |
The study of the activity of isoenzymes of cytochrome P450 for the prediction of drug-drug interactions of medicines in terms of polypharmacy |
Abstract
PDF (Rus)
|
|
D. A. Sychev, V. A. Otdelenov, N. P. Denisenko, V. V. Smirnov |
| |
| No 1 (2015) |
Sex differences as a platform for understanding the pharmacological status of women |
Abstract
PDF (Rus)
|
|
O. V. Reshetko, K. A. Lutsevich |
| |
| No 1 (2015) |
Genetic, pathophysiological and clinical aspects of antiplatelet therapy (review) |
Abstract
PDF (Rus)
|
|
E. M. Zelenskaya, A. A. Slepuhina, N. V. Koch, K. A. Apartsyn, G. I. Lifshits |
| |
| No 2 (2015) |
Arterial hypertension: molecular-genetic and pharmacogenetic approaches |
Abstract
PDF (Rus)
|
|
N. V. Kokh, A. A. Slepukhina, G. I. Lifshits |
| |
| No 2 (2015) |
Cough and angioedema from angiotensin-converting enzyme inhibitors: genetic markers |
Abstract
PDF (Rus)
|
|
I. S. Dantsev, I. I. Sinitsina, D. A. Sychev |
| |
| No 1 (2019) |
Relevance of creating a personalized approach to stimulation of superovulation in vitro fertilization programs |
Abstract
PDF (Rus)
|
|
A. V. Lapshtaeva, T. J. Eremkina, I. V. Sychev |
| |
| No 1 (2019) |
Pharmacogenetic aspects of the efficacy and safety of trazodone therapy |
Abstract
PDF (Rus)
|
|
V. S. Dobrodeeva, N. A. Shnayder, R. F. Nasyrova |
| |
| No 1 (2017) |
Some molecular genetic mechanisms of the obesity and metabolic syndrome |
Abstract
PDF (Rus)
|
|
G. I. Lifshits, N. V. Kokh, V. V. Kireeva, K. A. Apartsin |
| |
| No 1 (2017) |
Pharmacogenetic features of the phase II biotransformation of tamoxifen: a systematic review |
Abstract
PDF (Rus)
|
|
M. I. Savelyeva, I. A. Urvantseva, A. K. Ignatova, J. S. Panchenko, I. V. Poddubnaya |
| |
| No 1 (2017) |
Pharmacogenetics of dabigatran etexilate - the role of CES1 and ABCB1 polymorphisms |
Abstract
PDF (Rus)
|
|
D. A. Sychev, I. U. Meshcheriakov |
| |
| No 1 (2018) |
New data on pharmacogenetics in development of arterial hypertension and effectiveness of amlodipine |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 1 (2018) |
The value polymorphism in gen KCNJ11, ABCC8 and TCF7L2 for response to therapy of the main oral hypoglycemic drugs |
Abstract
PDF (Rus)
|
|
P. B. Shorokhova, K. A. Zagorodnikova, V. L. Baranov, N. V. Vorokhobina |
| |
| No 1 (2018) |
Pharmacogenetic aspects of the efficacy and safety profile of H1-histamine receptor blockers in the treatment of allergic diseases |
Abstract
PDF (Rus)
|
|
A. K. Zastrozhina, D. A. Suchev |
| |
| No 1 (2018) |
Genetic background vitamin D deficiency and modern methods of its correction in children |
Abstract
PDF (Rus)
|
|
E. M. Zelenskaya, G. I. Lifshits |
| |
| 1 - 26 of 26 Items |
|
